Experienced in T-Cell Lymphoma
Experienced in T-Cell Lymphoma
195 Little Albany St, 
New Brunswick, NJ 

Overview

Peter Cole is a Pediatric Hematologist Oncology provider in New Brunswick, New Jersey. Dr. Cole is rated as an Experienced provider by MediFind in the treatment of T-Cell Lymphoma. His top areas of expertise are Hodgkin Lymphoma, Acute Lymphoblastic Leukemia (ALL), Leukemia, and Classical Hodgkin Lymphoma.

His clinical research consists of co-authoring 84 peer reviewed articles and participating in 27 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has participated in 2 clinical trials in the study of T-Cell Lymphoma.

Specialties
Pediatric Hematology Oncology
Licenses
Pediatric Hematology-Oncology in NJ
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
View 1 Less Insurance Carrier -

Locations

195 Little Albany St, New Brunswick, NJ 08901

Additional Areas of Focus

Dr. Cole has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Immune Thrombocytopenic Purpura (ITP)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


27 Clinical Trials

Neuroblastoma Biology Studies
Risk-Stratified Randomized Phase III Testing of Blinatumomab (NSC#765986) in First Relapse of Childhood B-Lymphoblastic Leukemia (B-ALL)
Randomized Phase 3 Trial Evaluating the Addition of the IGF-1R Monoclonal Antibody Ganitumab (AMG 479, NSC# 750008) to Multiagent Chemotherapy for Patients With Newly Diagnosed Metastatic Ewing Sarcoma
A Comprehensive Approach to Improve Medication Adherence in Pediatric ALL
A Phase III Randomized Trial for Newly Diagnosed High Risk B-Lymphoblastic Leukemia (B-ALL) Including a Stratum Evaluating Dasatinib (NSC#732517) in Patients With Ph-like Tyrosine Kinase Inhibitor (TKI) Sensitive Mutations
Utilizing Response- and Biology-Based Risk Factors to Guide Therapy in Patients With Non-High-Risk Neuroblastoma
Treatment of Children With All Stages of Hepatoblastoma With Temsirolimus (NSC#683864) Added to High Risk Stratum Treatment
A Randomized Phase 3 Study of Brentuximab Vedotin (SGN-35) for Newly Diagnosed High-Risk Classical Hodgkin Lymphoma (cHL) in Children and Young Adults
Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Children and Adolescents
Treatment of Patients With Newly Diagnosed Standard Risk B-Lymphoblastic Leukemia (B-ALL) or Localized B-Lineage Lymphoblastic Lymphoma (B-LLy)
Phase III Randomized Trial of Post-Radiation Chemotherapy in Patients With Newly Diagnosed Ependymoma Ages 1 to 21 Years
A Phase II Study for the Treatment of Non-metastatic Nodular Desmoplastic Medulloblastoma in Children Less Than 4 Years of Age
View 26 Less Clinical Trials
Similar Doctors
Experienced in T-Cell Lymphoma
Pediatric Hematology Oncology
Experienced in T-Cell Lymphoma
Pediatric Hematology Oncology
3401 Civic Center Blvd, Children's Hospital Of Philadelphia - Hem/onc, 
Philadelphia, PA 
 (54.6 miles away)
Languages Spoken:
English

Yael Mosse is a Pediatric Hematologist Oncology provider in Philadelphia, Pennsylvania. Dr. Mosse is rated as a Distinguished provider by MediFind in the treatment of T-Cell Lymphoma. Her top areas of expertise are Neuroblastoma, Embryonal Tumor with Multilayered Rosettes, Hereditary Neuroblastoma, and Rhabdomyosarcoma.

Experienced in T-Cell Lymphoma
Pediatric Hematology Oncology
Experienced in T-Cell Lymphoma
Pediatric Hematology Oncology
550 First Ave, NYU Langone Medical Center, 
New York, NY 
 (30.1 miles away)
Languages Spoken:
English

Kaitlin Devine is a Pediatric Hematologist Oncology provider in New York, New York. Dr. Devine is rated as an Advanced provider by MediFind in the treatment of T-Cell Lymphoma. Her top areas of expertise are Acute Lymphoblastic Leukemia (ALL), T-Cell Lymphoma, Febrile Neutropenia, and Ewing Sarcoma.

Experienced in T-Cell Lymphoma
Pediatric Hematology Oncology
Experienced in T-Cell Lymphoma
Pediatric Hematology Oncology
40 Sunshine Cottage Rd, Munger Pavilion, Room 110, 
Valhalla, NY 
 (52.7 miles away)
Languages Spoken:
English

Nader El is a Pediatric Hematologist Oncology provider in Valhalla, New York. Dr. El is rated as an Advanced provider by MediFind in the treatment of T-Cell Lymphoma. His top areas of expertise are Adult Soft Tissue Sarcoma, Langerhans Cell Histiocytosis, Reticulohistiocytoma, and Histiocytosis.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Cole's expertise for a condition
ConditionClose
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile